Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer

University of Southern California · with National Cancer Institute (NCI) · NCT07076147

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 30–75 · Women only
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
150
US sites recruiting
2
Study start
June 2, 2025
Record last updated
June 1, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This study assesses breast cancer screening adherence for women at moderately increased risk for developing breast cancer based on gene mutation status or empiric risk model estimates. It also seeks to determine facilitators and barriers to screening.

Being studied: Non-Interventional Study

Conditions: Breast Carcinoma

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • * >= 30 years
  • =\< 75 years
  • Women with either:
  • Genetic test results showing moderately increased breast cancer risk due to a pathogenic/likely pathogenic variant in ATM, CHEK2, BARD1, RAD51C, or RAD51D (Mutation carrier group) OR
  • Calculated lifetime breast cancer risk estimates between 20% and 40% according to the Tyrer-Cuzick V8.0B empiric risk model (Empiric risk group)
  • Patients provided breast cancer risk assessments by genetic counselors at USC Norris or LA General Hospital beginning in 2021 and at least 12 months ago
  • Women recommended to undergo annual breast MRI and/or annual mammogram beginning at the time of their genetic counseling risk assessment
  • English or Spanish speaking patients

Exclusion Criteria

  • * History of breast cancer before genetic counseling at University of Southern California (USC)
  • Any metastatic cancer diagnosis at time of genetic counseling risk assessment
  • Deceased
  • Patient underwent a risk reducing mastectomy before their genetic counseling risk assessment

Recruiting US locations

  • Los Angeles General Medical Center

    Los Angeles, CA 90033

    Site contact: Jacob Comeaux · 323-865-0474 · Jacob.Comeaux@med.usc.edu

  • USC / Norris Comprehensive Cancer Center

    Los Angeles, CA 90033

    Site contact: Jacob Comeaux · 323-865-0474 · Jacob.Comeaux@med.usc.edu

All healthy volunteers studies in California →
Breast Cancer Screening Adherence for Women at Moderate Risk for… (NCT07076147) | Bored Studies